1 completed. .
Follow Ionetix Corporation: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ammonia N-13 Myocardial Blood Flow Absolute Quantification by PET in Patients With Known or Suspected CAD (Ammonia MAP) Myocardial Perfusion Imaging Study, AMMONIA N-13 37.5 mCi in 1 mL INTRAVENOUS INJECTION [Ammonia N 13] - Myocardial Ischemia, Coronary Disease | Completed | Ionetix Corporation | 170 | 2020-09-14 | 2024-09-05 |
Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Cardiovascular Diseases (1) · Coronary Artery Disease (1) · Coronary Disease (1) · Heart Diseases (1) · Myocardial Ischemia (1) · Vascular Diseases (1)
United States (1)
Joseph Oliverio (1)
PMID 1269083, PMID 1900224, PMID 21492816, PMID 21816311, PMID 22007073, PMID 27539843, PMID 2788669, PMID 8106689, PMID 8229231, PMID 8890809